Todd Verdoorn
2018
In 2018, Todd Verdoorn earned a total compensation of $423.4K as Chief Scientific Officer at DiaMedica Therapeutics, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $36,000 |
|---|---|
| Option Awards | $156,848 |
| Salary | $221,667 |
| Other | $8,867 |
| Total | $423,382 |
Verdoorn received $221.7K in salary, accounting for 52% of the total pay in 2018.
Verdoorn also received $36K in non-equity incentive plan, $156.8K in option awards and $8.9K in other compensation.
Rankings
In 2018, Todd Verdoorn's compensation ranked 12,374th out of 14,244 executives tracked by ExecPay. In other words, Verdoorn earned more than 13.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,374 out of 14,244 | 13th |
Division Manufacturing | 5,013 out of 5,765 | 13th |
Major group Chemicals And Allied Products | 1,899 out of 2,128 | 11th |
Industry group Drugs | 1,626 out of 1,817 | 11th |
Industry Pharmaceutical Preparations | 1,246 out of 1,391 | 10th |
Source: SEC filing on April 8, 2019.
Verdoorn's colleagues
We found two more compensation records of executives who worked with Todd Verdoorn at DiaMedica Therapeutics in 2018.